Suppr超能文献

雌激素受体α和β表达与乳腺癌原发肿瘤及淋巴结转移中Ki-67、Bcl-2和Bak的相关性:术前化疗的影响

ERα and ERβ expression in correlation with Ki-67, Bcl-2 and Bak in primary tumors and lymph node metastases of breast cancer: The effect of pre-operative chemotherapy.

作者信息

Kanczuga-Koda Luiza, Koda Mariusz, Tomaszewski Jakub, Jarzabek Katarzyna, Lotowska Joanna, Baltaziak Marek, Sulkowska Urszula, Sobaniec-Lotowska Maria, Sulkowski Stanisław

机构信息

Department of Pathology, Maria Sklodowska-Curie Memorial Bialystok Oncology Center, 15-027 Bialystok.

出版信息

Oncol Lett. 2010 Nov;1(6):1067-1071. doi: 10.3892/ol.2010.178. Epub 2010 Sep 23.

Abstract

This study aimed to assess the pre-operative chemotherapy impact on the relationship between estrogen receptor (ER) expression and markers of proliferation and apoptosis in primary and metastatic breast cancer. Immunohistochemical examinations were conducted on surgically removed ductal invasive breast cancers and their lymph node metastases in 135 patients. A total of 64 patients from this group underwent pre-operative chemotherapy and in 71 cases the surgery was performed without primary chemotherapy. A negative correlation between ERα and Ki-67 was found in primary tumors and lymph node metastases. A positive correlation was observed between ERα and Bcl-2. A positive correlation was also noted between ERβ and Bak, suggesting that the two ERs were involved in the regulation of proteins responsible for the control of the apoptotic process. Assessment of the expression of the proteins conducted separately in primary tumors and lymph node metastases did not reveal a significant effect of pre-operative chemotherapy on the correlations of ERs with Ki-67, Bcl-2 and Bak. However, the analysis of the correlations between the receptor expression in primary tumors and Ki-67, Bcl-2 and Bak in lymph node metastases showed a statistically significant impact of pre-operative chemotherapy on the correlations of ERα and Bcl-2 with ERβ and Bak, confirming involvement of the two ERs in the regulation of apoptosis during breast carcinogenesis.

摘要

本研究旨在评估术前化疗对原发性和转移性乳腺癌中雌激素受体(ER)表达与增殖及凋亡标志物之间关系的影响。对135例患者手术切除的乳腺导管浸润癌及其淋巴结转移灶进行了免疫组织化学检查。该组中共有64例患者接受了术前化疗,71例患者未进行术前化疗直接接受了手术。在原发性肿瘤和淋巴结转移灶中发现ERα与Ki-67呈负相关。观察到ERα与Bcl-2呈正相关。还注意到ERβ与Bak呈正相关,表明两种ER均参与了负责调控凋亡过程的蛋白质的调节。分别在原发性肿瘤和淋巴结转移灶中进行的蛋白质表达评估未显示术前化疗对ER与Ki-67、Bcl-2和Bak之间的相关性有显著影响。然而,对原发性肿瘤中受体表达与淋巴结转移灶中Ki-67、Bcl-2和Bak之间相关性的分析显示,术前化疗对ERα和Bcl-2与ERβ和Bak之间的相关性有统计学上的显著影响,证实了两种ER在乳腺癌发生过程中参与了凋亡调控。

相似文献

5
Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases.
J Clin Pathol. 2005 Jun;58(6):645-9. doi: 10.1136/jcp.2004.022590.
7
Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues.
Pathol Res Pract. 2012 Mar 15;208(3):133-9. doi: 10.1016/j.prp.2011.12.015. Epub 2012 Feb 14.

引用本文的文献

1
High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel.
PLoS One. 2015 Sep 25;10(9):e0138955. doi: 10.1371/journal.pone.0138955. eCollection 2015.
2
Estrogen regulation of anti-apoptotic Bcl-2 family member Mcl-1 expression in breast cancer cells.
PLoS One. 2014 Jun 27;9(6):e100364. doi: 10.1371/journal.pone.0100364. eCollection 2014.

本文引用的文献

1
Systemic therapy of metastatic breast cancer: the truth beyond the clinical trials.
Oncology. 2009;76(4):247-53. doi: 10.1159/000205387. Epub 2009 Feb 25.
2
3
Current research topics in endocrine therapy for breast cancer.
Int J Clin Oncol. 2008 Oct;13(5):380-3. doi: 10.1007/s10147-008-0818-7. Epub 2008 Oct 23.
5
Overview of resistance to systemic therapy in patients with breast cancer.
Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1.
10
Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases.
J Clin Pathol. 2005 Jun;58(6):645-9. doi: 10.1136/jcp.2004.022590.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验